AV

Andrew von Eschenbach

Houston, US

About

Dr. von Eschenbach served as Commissioner of the U.S. Food and Drug Administration from 2005 until 2009 where he engaged an agenda to modernize the FDA. Under his leadership, many new programs were designed to strengthen the FDA, including the establishment of a nanotechnology initiative. He emphasized the FDA’s role in working with external partners to assure quality throughout the entire life cycle of the products it regulates while internally fostering, through process improvements, a regulatory pathway that is transparent and efficient while still rigorous and science led. Currently, Dr. von Eschenbach serves as Senior Director for Strategic Initiatives at the Center for Health Transformation, founded by Newt Gingrich, and leads the 21st Century FDA Modernization Project. Dr. von Eschenbach joined the FDA after serving for four years as Director of the National Cancer Institute (NCI) at the National Institutes of Health where he set an ambitious goal to eliminate the suff

Investment Focus

Location
Houston, US

Contact Information

em••••@example.com
linkedin.com/in/••••••••

Unlock contact details with a VCSift subscription

Unlock Contact

Already subscribed? Log in

Find more investors like Andrew

Search Investors